Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing.
Achar, J
; Seddon, JA; Knight, GM; Dodd, PJ; Esmail, H; Hughes, J; McQuaid, CF and
(2023)
Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing.
The European Respiratory Journal, 62 (5).
p. 2300969.
ISSN 0903-1936
DOI: 10.1183/13993003.00969-2023
; Seddon, JA; Knight, GM; Dodd, PJ; Esmail, H; Hughes, J; McQuaid, CF and
(2023)
Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing.
The European Respiratory Journal, 62 (5).
p. 2300969.
ISSN 0903-1936
DOI: 10.1183/13993003.00969-2023
-
picture_as_pdf - Achar_etal_2023_Guiding-pragmatic-treatment-choices.pdf
-
subject - Published Version
-
error - This is an author accepted manuscript version of an article accepted for publication and following peer review. Please be aware that minor differences may exist between this version and the final version if you wish to cite from it.
-
copyright - Available under Copyright the publishers
Downloads